Costs of implementing a multi-site facilitation intervention to increase access to medication treatment for opioid use disorder.

ABSTRACT:

Background

The United States has been grappling with the opioid epidemic, which has resulted in over 75,000 opioid-related deaths between April 2020 and 2021. Evidence-based pharmaceutical interventions (buprenorphine, methadone, and naltrexone) are available to reduce opioid-related overdoses and deaths. However, adoption of these medications for opioid use disorder has been stifled due to individual- and system-level barriers. External facilitation is an evidence-based implementation intervention that has been used to increase access to medication for opioid use disorder (MOUD), but the implementation costs of external facilitation have not been assessed. We sought to measure the facility-level direct costs of implementing an external facilitation intervention for MOUD to provide

SUBMITTER: Garcia CC 

PROVIDER: S-EPMC10413546 | biostudies-literature | 2023 Aug

REPOSITORIES: biostudies-literature